Anti Seizure Meds Flashcards
Risk with all anti seizure drugs
- depression and increased suicidality
- microsomal enzyme interactions
~ CYP3A4 inducers: phenytoin (phospho), phenobarbital,
carbamazepine, oxcarbazepine and topiramate
~ CYP2C9 inhibitors: valproate
~ CYP2C1 inhibition: topiramate
Absence trt
Treated with Ca channel drug (ethosuximide, valproic acid, clonezapam)
Phenytoin: MOA, use, consideration
- 0th order kinetics (only fosphenytoin used anymore)
- used for all types sans absence
- MOA: prolong Na channel inactivation
- many CYP enzymes
- highly protein bound: hymoalbuminemic -> increased toxicity
Azapines (carbam, oxam)
- MOA: decreases Na influx
- Indication: Tonic clonic, partial complex, neuropathic pain, bipolar disorder, paresthesia, PTSD
- SE: Diplopia, ataxia, cognitive dysfunction, rare aplastic anemia and hepatotoxicity
- carb: lots of microsomal interactions
- ox: CYP3A4 only
- ox can result in hyponatremia
Lamotrigine
- MOA: Na + Ca channel
- partial, tonic-clonic, bipolar
- SE: dizziness, ataxia, visual disturbances, Stevens-Johnson’s
- lots of drug interactions
Topiramate
- MOA: Na channel modulation, potentiates GABA/blocks AMPA
- partial, binge eating, PTSD
- SE: dizziness, drowsiness, ataxia, psychomotor slowing, memory impairment, weightloss, myopia
- weightloss SE exploited pharmacologically
- induces 3A4, inhibits 2C19 and excreted unchanged
Valproic acid
- blocks t type Ca channels, and acts on Na
- treats everything but bipolar
- SE: hepatotoxicity, nausea, tremor, weight gain and hair loss
- inhibition of 2C9; induction of 2A6
- NOT for kids under 2 (caution in kids under 6)
- NTDs
Gabapentin
- MOA: Voltage gaited Ca channel blockers
- adjunct: neuropathic pain, parasthesis, PTSD, mania
- excreted unchanged in urine, FEW INTERACTIONS
- SE: sedation, dizziness, ataxia, nystagmus, mood disorders in kids
Pregabalin
- MOA: binds to N-type Ca channels
- adjunct for partial seizures; neuropathic pain, fibro
- similar to gabapentin with less interactions and side effects
Levetiracetam
- MOA: not listed
- excreted in urine, few interactions
- SE: sedation, dizziness, weakness and ataxia
- rare side effects irritability, hallucinations, psychosis
Benzodiazepines
- MOA: GABA enhancement
- IV or rectal benzos for STATUS EPTILEPTICUS
- SE: sedation (hyperactivity in kids) and tolerance
- Clonazepam for absence; less sedating at anticonvulsant doses
Phenobarbital
- tonic/clonic, partial
- SE: Severely sedating, cognative dysfunction, tolerance, dependance, nystagmus, ataxia, osteomalacia (chronic use) decreased D and K,
- Cind: porphyrias
Ethosuximide*
Specific for absence
Lacosamide*
- cardiac effects
- C - V controlled substance
Primidone*
Cognative impairment
CYP inducer
Rufinamide*
- Lennox-Gestaut epilepsy only
Tiagabine *
Adjunct
Vigabatrin
Renal excretion
few drug interactions
Visual impairment
- trt for west syndrome
Zonisamide
Sulfa drug
Nephropethiasis (more risk than with topiramate)
SJ syndrome
Ezogabine
- MOA: opens K channels
- adjuvant therapy
- SE: dizziness, Sleepiness, urinary retention, urine discoloration
- increases digoxin lvls
- increased metabolism when combined with phenytoin or carbamazepine
Phen, phen, carb, carb, top
CYP 3A4 inducers
- phenytoin, phenobarbital, carbamazepine, oxcarbazepine, topiramate
2C19
Inhibitor: valproic acid
Inducer: topiramate
Calcium channel blockers (4)
- valproic acid
- gabapentin
- pregabalin
- lamotrigine
GABA enhancement (3)
Valproic acid
Levetiracetam
Topiramate